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Purpose: To study the seasonal variability in the occurrence of acute retinal necrosis
(ARN) in a series of polymerase chain reaction (PCR)-positive patients.
Methods: Consecutive patients clinically diagnosed with ARN and a positive PCR result
of aqueous humor during a seven-year period were studied retrospectively. Patients’
demographics, causative viral agent(s), and the date of disease onset were extracted
from medical records.
Results: Twenty eyes of 20 patients were enrolled; the mean age at presentation was
39.6± 14.4 (range, 6–62) years. Nine patients were female. The most common causative
agent was varicella-zoster virus in 16 patients (80%), followed by herpes simplex virus in
two patients (10%). The disease onset was in winter in 10 patients (50%), and the highest
incidence was in February (five patients, 25%). The cumulative occurrence of ARN was
significantly higher in the first half of the year (winter and spring) compared to the second
half of the year (summer and fall) (P = 0.030). In general, seasons with a high incidence
of ARN were preceded by cold seasons.
Conclusion: In our series, we observed seasonal variability in the incidence of ARN, with
the highest incidence during winter and spring. However, further epidemiologic studies
in different geographical areas are required to elucidate the true seasonal nature of ARN.
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Acute retinal necrosis (ARN) was first described
in 1971 by Urayama et al as a syndrome of acute
panuveitis with retinal periarteritis progressing to
diffuse necrotizing retinitis and retinal detachment
(RD).[1] This uncommon but potentially blinding
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condition is usually noticed in immunocompetent
hosts but occasionally among immunocompro-
mised patients.[2, 3] In a nationwide survey in the
UK, the estimated incidence of ARN was one case
per 2 million people per year, which had been
stable over one decade.[4, 5]
ARN is caused by members of the Herpesviridae
family, most commonly varicella-zoster virus (VZV)
and herpes simplex virus (HSV), and occasion-
ally Epstein–Barr virus (EBV) and cytomegalovirus
(CMV).[6–8] Although ARN is essentially a clinical
diagnosis, ocular fluid polymerase chain reaction
(PCR) testing has been widely used as an aid to
the diagnosis and identification of the causative
virus.[9–12]
ARN is a rapidly destructive disease. Systemic
antiviral therapy is the mainstay of treatment.
Corticosteroids are usually used alongwith antiviral
agents to reduce the ocular inflammation. Antivirals
hasten the remission of retinitis in the affected
eye and have a protective effect on the fel-
low eye.[13] Moreover, early laser retinopexy can
reduce the risk of RD,[14, 15] which is a complication
that is considered a major cause of poor visual
outcome in ARN.[16, 17] Therefore, early diagnosis
and prompt management are important for reduc-
ing ocular morbidity, and can potentially save
a significant number of eyes from severe vision
loss.
In this retrospective chart review, we observed
a clustering tendency in the occurrence of ARN in
specific months of the year; this observation could
highlight important aspects of the epidemiology of
the disease.
METHODS
We retrospectively reviewed the medical records
of patients diagnosed with ARN at two referral
centers in Tehran from January 2011 to Decem-
ber 2017. Only eyes with positive aqueous PCR
were included. The study protocol was approved
by the Institutional Review Boards, and informed
consent was obtained from the participants at the
time of anterior chamber paracentesis. Data on
the demographics, causative viral agent(s), and
date of the start of the ocular symptoms (consid-
ered as disease onset) were extracted. ARN was
clinically diagnosed based on the characteristic
clinical features consisting of the presence of
one or multiple peripheral foci of retinitis with
rapid circumferential progression, occlusive retinal
vasculitis (mainly arteritis), and prominent vitreous
inflammation. Wide-field fluorescein angiography
was used to confirm the occlusive nature of vas-
culitis and extent of retinal ischemia. A tailored
laboratory work-up was performed to assess the
immune status of the patients and rule-out other
causes of uveitis. The average temperatures in
each month from January 2011 to December 2017
were extracted based on the data provided by
theWorldWeatherOnline.com in Tehran, Mehrabad
Airport.
Technique of anterior chamber paracentesis
and PCR
For aqueous sampling, anterior chamber
paracentesis was performed using a 30-gauge
needle attached to an insulin syringe, and 0.1–
0.2 cc of aqueous humor was aspirated. The
procedure was generally performed in the
clinic after the examination. For patients who
received an intravitreal injection of ganciclovir,
both sampling and injection were performed in
the operating room. The samples were kept at
2–8∘C and delivered to the laboratory within
1 h and were stored at –20∘C. DNA extraction
was performed within one week using High
Pure Viral Nucleic Acid Kit (Roche Diagnostics
GmbH, Mannheim, Germany) following the
manufacturer’s instructions.[18] Qualitative PCR
was performed using the flash method by the
DNA Technology Kit (DNA-Technology, Moscow,
Russia).[19]
The results are expressed as mean ± standard
error. Due to the limited number of cases, Fisher’s
exact test was used to compare the cumulative
occurrence of ARN between the first and second
halves of the year. A p-value<0.05was considered
statistically significant.
RESULTS
Twenty eyes of 20 patients were included in this
study. The mean age at presentation was 39.6
± 14.4 (range: 6–62) years. Nine patients were
female. None of the patients were HIV-positive.
ARN was unilateral in all patients except one [Table
1]. The patient with bilateral ARN did not consent
for bilateral sampling, therefore, only the eye with
more extensive involvement was sampled (positive
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Table 1. Demographics, causative viral agent(s), and date of disease onset in ARN cases
Patient # PCR result Gender Age at onset (years) Laterality ARN onset (month) ARN onset (year)
1 VZV M 41 OD 6 2013
2 VZV M 30 OS 5 2014
3 VZV F 56 OD 1 2016
4 VZV F 28 OS 4 2013
5 VZV M 58 OD 10 2015
6 VZV M 53 OS 2 2011
7 VZV M 45 OD 5 2012
8 VZV F 44 OU 8 2013
9 VZV F 45 OD 6 2017
10 VZV M 40 OD 1 2015
11 VZV M 21 OS 2 2017
12 VZV F 35 OS 2 2016
13 VZV M 48 OS 1 2017
14 VZV M 56 OS 3 2015
15 VZV F 29 OD 3 2015
16 VZV, EBV F 62 OS 4 2016
17 HSV M 6 OS 2 2017
18 HSV M 25 OD 2 2014
19 EBV F 26 OD 3 2017
20 CMV M 43 OD 5 2014
ARN, acute retinal necrosis; CMV, cytomegalovirus; EBV, Epstein–Barr virus; F, female; HSV, Herpes Simplex virus; m, male; OD,
right eye; OS, left eye; OU, bilateral; PCR, polymerase chain reaction; VZV, Varicella-Zoster Virus
for VZV) while the other eye was excluded from the
study.
Based on the PCR results, the most common
causative agent was VZV detected in 16 patients
(80%), followed by HSV in 2 patients (10%; HSV-1
and HSV-2 each in one patient). CMV was detected
in one patient (5%) and EBV in one eye (5%). In one
VZV-positive patient, a simultaneous co-infection
by EBV was present [Table 1].
In most patients (85%, 17 patients), the dis-
ease onset was in winter (ten patients, 50%)
or spring (seven patients, 35%). Summer (two
patients, 10%) and autumn (one patient, 5%) were
the seasons with the lowest incidence [Figure
1(a)]. February was the month with the highest
incidence of ARN (five patients, 25%), and July,
September, November, and December were the
months with the lowest incidence (no cases)
[Figure 1(b)]. The cumulative occurrence of ARN
was significantly higher in the first half of the
year (winter and spring) compared to the sec-
ond half of the year (summer and fall) (P =
0.030).
Figure 2 shows the average temperature in
each month during the study period. The cold-
est month in the study period was January
(mean temperature, 5.1∘C), followed by Febru-
ary (mean temperature, 6.5∘C) and December
(mean temperature, 7.0∘C). July (mean tempera-
ture, 34.0∘C), August (mean temperature, 32.9∘C),
and June (mean temperature, 31.7∘C) were the
warmest months. The coldest season that was
winter (average temperature, 7.7∘C) had the high-
est incidence of ARN (50%). Autumn, which was
the second coldest season (average temperature,
12.9∘C), had the lowest incidence of ARN (5%).
The high incidence rate of ARN (35%) in spring
suggests a time lag between the beginning of
cold seasons and an increase in the incidence of
ARN.
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Figure 1. Cumulative number of cases of acute retinal necrosis in each season (a) and month (b).
DISCUSSION
In this series, there was a tendency for the occur-
rence of ARN during winter and spring. The sea-
sons with a high incidence of ARN were preceded
by cold seasons. While the temperature began
dropping mid-autumn, the peak of ARN occurred
during winter, and once the temperature started
rising mid-spring, the incidence of ARN declined in
summer.
Previous studies have shown patterns of sea-
sonal variability in the incidence of infections
associated with the Herpesviridae family. Varicella
shows pronounced seasonality in temperate cli-
mates and most tropical climates, with a peak
incidence in the cooler, drier months during winter
or spring.[20–23] In a study using the Connecticut
statewide hospital discharge database in the pre-
vaccine era, 73.2% of the varicella hospitalizations
occurred during winter and spring.[24] In contrast,
zoster does not show any seasonal pattern in the
UK, Canada,[25] or Western Australia.[26] Seasonal
variations in the occurrence of herpetic kerati-
tis were reported as well. In a study in Japan,
a negative correlation was observed between
the incidence of dendritic keratitis recurrences
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Figure 2. Average temperature in each month in the study period.
and temperature and 42.2% of the recurrences
occurred during winter.[27] Gamus found the high-
est rate of herpetic eye attacks during January,[28]
and others reported the highest incidence of her-
petic keratitis in late autumn and winter.[29]
Seasonal cycles in infectious diseases are gen-
erally attributed to seasonal differences in weather
conditions, seasonal rhythmicity in host susceptibil-
ity to infectious agents, and the virulence or preva-
lence of causal pathogens.[30, 31] The explanation
of the seasonal variability in the incidence of ARN
in this series would be undoubtedly complex and
multifactorial. Tehran has a four-season climate.
The weather is usually mild and rainy in spring,
hot and dry in summer, mild to cold in autumn, but
chilly and occasionally snowy in winters. Records
of the average monthly temperature also showed
that winter and autumn were the coldest seasons.
The higher incidence rate of ARN in winter and
spring suggests a temporal pattern in which the
cold seasons preceded seasons with a high inci-
dence of ARN. However, this is an assumption
and cannot be confirmed using statistical methods.
Administering the time series analysis, which is
often used to extract possible correlations in similar
situations, needs a large sample size far exceeding
the number of cases included in the current study.
To the best of our knowledge, this is the
first report on the concept of seasonality in
ARN. We included a homogenous group of
patients with PCR-proven ARN and set Tehran,
a four-season city, as the reference to evaluate
the probable climatological association. A limi-
tation of the current study is the small sample
size, which is due to the rarity of ARN. The
second limitation is that the temperature data
were collected based on records provided from
a single station in Tehran (Mehrabad Airport).
Considering the area of the Tehran metropoli-
tan, a single station may not comprehensively
reflect the whole climate of the source popula-
tion.
The knowledge of the seasonal variability in the
incidence of ARN could potentially be beneficial
to ophthalmologists to expect new cases during
specific months of the year and be prompt in
diagnosis and treatment. However, further epi-
demiologic studies in different geographical areas
are required to elucidate the true seasonal nature
of ARN.
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